{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:01:54Z","timestamp":1791151314683,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.oooo.2013.03.017","type":"journal-article","created":{"date-parts":[[2013,5,10]],"date-time":"2013-05-10T05:02:27Z","timestamp":1368162147000},"page":"e185-e190","source":"Crossref","is-referenced-by-count":20,"title":["Hypereosinophilic syndrome \u2013 lymphocytic variant transforming into peripheral T-cell lymphoma with severe oral manifestations"],"prefix":"10.1016","volume":"116","author":[{"given":"J.M.","family":"d'Elb\u00e9e","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Parrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Merci\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Longy Boursier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Dieval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"de Mascarel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Duffau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Dubus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"Fricain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oooo.2013.03.017_bib1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.revmed.2009.05.008","article-title":"Hypereosinophilic syndromes: pathogenic and therapeutic up-to-date","volume":"3","author":"Kahn","year":"2010","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.oooo.2013.03.017_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1586\/ehm.11.81","article-title":"Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field","volume":"5","author":"Valent","year":"2012","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.oooo.2013.03.017_bib3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1586\/ehm.12.14","article-title":"Clinical management of the hypereosinophilic syndromes","volume":"5","author":"Cogan","year":"2012","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.oooo.2013.03.017_bib4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaci.2012.02.019","article-title":"Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes","volume":"130","author":"Valent","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.oooo.2013.03.017_bib5","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","article-title":"A\u00a0tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"348","author":"Cools","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.oooo.2013.03.017_bib6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1056\/NEJM199402243300804","article-title":"Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome","volume":"330","author":"Cogan","year":"1994","journal-title":"N\u00a0Engl J\u00a0Med"},{"key":"10.1016\/j.oooo.2013.03.017_bib7","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1046\/j.1365-2141.2000.02097.x","article-title":"Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome","volume":"109","author":"Roufosse","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.oooo.2013.03.017_bib8","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/ajh.23293","article-title":"World Health Organization-defined eosinophilic disorders: 2012 update on diagnosis, risk stratification, and management","volume":"87","author":"Gotlib","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.oooo.2013.03.017_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jaci.2010.04.011","article-title":"Practical approach to the patient with hypereosinophilia","volume":"126","author":"Roufosse","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.oooo.2013.03.017_bib10","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1182\/blood-2006-10-050054","article-title":"Low-dose imatinib mesylate leads to rapid induction of major molecular responses\u00a0and achievement of complete molecular remission in\u00a0FIP1L1\u2013PDGFRA-positive chronic eosinophilic leukemia","volume":"109","author":"Jovanovic","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.oooo.2013.03.017_bib11","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.leukres.2005.11.011","article-title":"FIP1L1\u2013PDGFRA in eosinophilic disorders: prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature","volume":"30","author":"Pardanani","year":"2006","journal-title":"Leuk Res"},{"key":"10.1016\/j.oooo.2013.03.017_bib12","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/ajh.20423","article-title":"Hypereosinophilic syndrome: an update","volume":"80","author":"Wilkins","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.oooo.2013.03.017_bib13","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa070812","article-title":"Treatment of patients with the hypereosinophilic syndrome with mepolizumab","volume":"358","author":"Rothenberg","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.oooo.2013.03.017_bib14","first-page":"248","article-title":"Isolated mucosal ulcers disclosing idiopathic hypereosinophilic syndrome","volume":"124","author":"Billon","year":"1997","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.oooo.2013.03.017_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1601-0825.2007.01393.x","article-title":"Oral mucosal lesions in hypereosinophilic syndrome \u2013 an update","volume":"14","author":"Ionescu","year":"2008","journal-title":"Oral Diseases"},{"key":"10.1016\/j.oooo.2013.03.017_bib16","series-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"Bain","year":"2008"},{"key":"10.1016\/j.oooo.2013.03.017_bib17","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1002\/1097-0142(20001115)89:10<2138::AID-CNCR15>3.0.CO;2-W","article-title":"Lymphomatoid papulosis associated with both severe hypereosinophilic syndrome and CD30 positive large T-cell lymphoma","volume":"89","author":"Granel","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.oooo.2013.03.017_bib18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/10428190500275443","article-title":"Changing clinical manifestations of a T-peripheral lymphoma: from hypereosinophilic syndrome to questionable Kimura's disease resulting in parotid mass","volume":"47","author":"Beyazit","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.oooo.2013.03.017_bib19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3904\/kjim.2006.21.1.57","article-title":"Peripheral T-cell lymphoma-unspecified (PTCL-U) presenting with hypereosinophilic syndrome and pleural effusions","volume":"21","author":"Choi","year":"2006","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.oooo.2013.03.017_bib20","first-page":"207","article-title":"Mucosal ulcerations revealing primitive hypereosinophilic syndrome","volume":"13","author":"Barouky","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.oooo.2013.03.017_bib21","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1001\/jama.1982.03320320054032","article-title":"Recurrent incapacitating mucosal ulcerations. A prodrome of the hypereosinophilic syndrome","volume":"247","author":"Leiferman","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.oooo.2013.03.017_bib22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1001\/archderm.1996.03890290069009","article-title":"Specific mucosal erosions in hypereosinophilic syndrome. Evidence for eosinophil protein deposition","volume":"132","author":"Aractingi","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.oooo.2013.03.017_bib23","doi-asserted-by":"crossref","first-page":"336","DOI":"10.2169\/internalmedicine.43.336","article-title":"A\u00a0rare case of idiopathic hypereosinophilic syndrome involving the oral cavity associated with the esophagus and gastrointestinal tract","volume":"43","author":"Watanabe","year":"2004","journal-title":"Intern Med"},{"key":"10.1016\/j.oooo.2013.03.017_bib24","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2222.2008.02958.x","article-title":"Eosinophils: biological properties and role in health and disease","volume":"38","author":"Hogan","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.oooo.2013.03.017_bib25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.joms.2011.03.026","article-title":"Traumatic ulcerative granuloma with stromal eosinophilia: report of a case and literature review","volume":"70","author":"Chatzistamou","year":"2012","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2013.03.017_bib26","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.leukres.2008.12.001","article-title":"Success of short-term, higher-dose imatinib mesylate to induce clinical response in FIP1L1\u2013PDGFR-negative hypereosinophilic syndrome","volume":"33","author":"Butterfield","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.oooo.2013.03.017_bib27","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4065\/mcp.2009.0503","article-title":"Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update. Mayo Clinic Proceedings","volume":"85","author":"Tefferi","year":"2010","journal-title":"Mayo Clinic"},{"issue":"suppl","key":"10.1016\/j.oooo.2013.03.017_bib28","first-page":"ECR42","article-title":"The achievement of complete molecular remission after autologous stem cell transplantation for T-cell lymphoma with associated hypereosinophilia, rare aberration t(6;11) and elevated IL-4 and IgE","volume":"91","author":"Helbig","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.oooo.2013.03.017_bib29","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1046\/j.1523-1747.2001.01339.x","article-title":"The interferon inhibiting cytokine IK is overexpressed in cutaneous T cell lymphoma derived tumor cells that fail to upregulate major histocompatibility complex class II upon interferon-gamma stimulation","volume":"116","author":"Willers","year":"2001","journal-title":"J\u00a0Investig Dermatol"},{"key":"10.1016\/j.oooo.2013.03.017_bib30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/pbc.23224","article-title":"Intralesional interferon-\u03b1 for the treatment of bilateral conjunctival mucosa-associated lymphoid tissue lymphoma","volume":"59","author":"Holds","year":"2012","journal-title":"Pediatr Blood Cancer"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440313001776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440313001776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T23:29:41Z","timestamp":1539646181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212440313001776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S2212440313001776"],"URL":"https:\/\/doi.org\/10.1016\/j.oooo.2013.03.017","relation":{},"ISSN":["2212-4403"],"issn-type":[{"value":"2212-4403","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}